Disclosed herein are compositions and methods for modulating DNA methylation of one or more gene promoters treating a subject diagnosed with or suspected of having a disease or disorder characterized by DNA hypermethylat ion decreasing c myc expression increasing desmoplakin expression and inhibiting metastases.
